title: Potential treatments for food allergy.
abstract: This article presents an overview of potential treatments of food allergy, with an emphasis on various forms of immunotherapy (including oral immunotherapy, sublingual immunotherapy, epicutaneous immunotherapy, immunotherapy with modified food antigens, and immunotherapy with a recombinant peanut vaccine). Allergen nonspecific treatments, such as Chinese herbal formulas, probiotics/prebiotics, helminths, monoclonal antibodies, and toll-like receptor agonists, are also summarized.
authors.affiliation: Division of Allergy and Immunology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1198, New York, NY 10029, USA.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Albin
authors.affiliation: Division of Allergy and Immunology, Department of Pediatrics, Kravis Children's Hospital, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1198, New York, NY 10029, USA. Electronic address: anna.nowak-wegrzyn@mssm.edu.
authors.forename: Anna
authors.initials: A
authors.lastname: Nowak-Węgrzyn
mesh_terms: D000485:Allergens / Q000276:immunology; D000818:Animals; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003888:Desensitization, Immunologic / Q000379:methods*; D005512:Food Hypersensitivity / Q000628:therapy*; D006376:Helminths / Q000276:immunology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects*; D007155:Immunologic Factors / Q000627:therapeutic use; D000069444:Omalizumab; D019936:Probiotics / Q000627:therapeutic use; D051193:Toll-Like Receptors / Q000819:agonists
chemical_list: D000485:Allergens; D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D051193:Toll-Like Receptors; D000069444:Omalizumab
keywords: Desensitization; Food allergy; Food immunotherapy; Omalizumab; Tolerance